80 results
Page 4 of 4
8-K
EX-99.1
af8paqpm7 tq
12 Aug 20
Cassava Sciences Announces Second Quarter 2020 Financial Results and Mid-year Business Review
8:30am
8-K
EX-99.2
4kox6vach396tnx
3 Jun 20
Regulation FD Disclosure
5:29pm
8-K
EX-99.1
86lu5c3
15 May 20
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary Endpoint
8:20am
8-K
EX-99.1
w06nu
6 May 20
Cassava Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
8:16am
424B2
mf89bfq
5 May 20
Prospectus for primary offering
4:38pm
8-K
EX-99.1
m07lu0sep66
26 Mar 20
Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020
8:17am
8-K
EX-99.2
vpotj
6 Dec 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
xsy hs67ihv4j
29 Oct 19
Cassava Sciences Announces Recent Clinical Highlights and Third Quarter 2019 Financial Results
8:29am
8-K
EX-99.1
sqa 6eg8e7mii0p
9 Sep 19
Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients
7:45am
8-K
EX-99.1
n9yk1j0a
12 Aug 19
Cassava Sciences Announces Second Quarter 2019 Financial Results
3:05pm
8-K
EX-99.1
cqgpmsv
29 Apr 19
Cassava Sciences Reports First Quarter 2019 Financial Results
8:45am